Saliva Diagnostics (SALV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Price who wrote (524)	2/15/1997 2:26:00 PM
From: brad greene	of 3369

Dear Mike,Instock,Keiko?, Jeeza, Spent some time going through past posts. Sorry to all, Jezza first. Seems the spirit of banter had me... But..Shorting a stock at 3.50....Holy Cow.. you need a total crash and burn. Not that it can't happen, but in this case? Salv's market cap is about 40 million. We value the company's technology at many times that. We believe that FDA attitude, recent Epitope deal and shifting management/ownership focus makes an agreement with a far larger entity probable. We have reason to believe that such an event will come sooner rather than later. Management we feel is well aware of the fact that they are somewhat "under the gun". We support management at this point and believe they are working in our best interest. We believe SALV needs a 20,000 man sales force and deep-pocket help and muscle to get some work done with the FDA. There are several majors with whom SALV's products would make a nice fit. Although we have followed the same paths and drawn many of the same conclusions as Mike, we are thinking North American. Our reasoning is quite detailed and speculative...but Ciba-Geigy is on our short list and would be just fine. Good work Mike! We are looking for a Marketing agreement rather than a merger or buyout deal that might not fully reward shareholders for future growth potential. Again.... we are taking a longer term view of SALV product potential.... the H.pylori infection product in particular.. Have you ever had an endoscope procedure? Not Fun! Very Expensive! We know that SALV is in the process of expanding production for certain products many fold. Based on this and other posturing, (warrants) ect...They are not behaving like a company that is looking to be bought out. Who knows.... If it is a buyout, lets just hope that it's rich enough to please the investors who bought in at IPO prices. Again... The devil is in the details! Dr. Seymour....Thanks for posting Keiko...Small World! bg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next